Status: Enrolling
Investigator: Bincy Abraham
Study Coordinator: Beatriz Efron
Phone: 713.363.8890
The purpose of this study is to determine whether RPC1063 is effective in the treatment of Ulcerative Colitis (UC). ... Read more >
Status: Enrolling
Investigator: Bincy Abraham
Study Coordinator: Caroline Perry
Phone: 346.238.0307
This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label. ... Read more >
Status: Enrolling
Investigator: Bincy Abraham
Study Coordinator: Beatriz Efron
Phone: 713.363.8890
The purpose of this study is to compare the incidence of lymphoma in adult participants with moderate-to-severe ulcerative colitis who are treated with Simponi versus those treated with thiopurines. ... Read more >
Status: Enrolling
Investigator: Bincy Abraham
Study Coordinator: Caroline Perry
Phone: 346.238.0307
This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for IBD in a cohort of patients cared for by gastroenterologists across North America. Second ... Read more >
Status: Enrolling
Investigator: Bincy Abraham
Study Coordinator: Caroline Perry
Phone: 346.238.0307
A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease study is being conducted at the University of California San Francisco and 30 other sites around the United States who are part ... Read more >
Status: Enrolling
Investigator: Bincy Abraham
Study Coordinator: Caroline Perry
Phone: 346.238.0307
The purpose of this study is to monitor safety outcomes of patients who have taken Cimzia® as compared to a non- Cimzia® control population. The SECURE Registry's target enrollment is 3045 patients and its objective is to monitor patients for ap ... Read more >
